Topics

Sanofi, Translate Bio To Develop Novel MRNA Vaccine Candidate Against COVID-19

02:52 EDT 27 Mar 2020 | FinanzNachrichten

PARIS (dpa-AFX) - Sanofi (SNY, SNYNF) announced Friday that its vaccines global business unit Sanofi Pasteur and Translate Bio (TBIO), a clinical-stage messenger RNA or mRNA therapeutics company, ...

Original Article: Sanofi, Translate Bio To Develop Novel MRNA Vaccine Candidate Against COVID-19

NEXT ARTICLE

More From BioPortfolio on "Sanofi, Translate Bio To Develop Novel MRNA Vaccine Candidate Against COVID-19"

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...